BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11791380)

  • 1. [Results of treatment based on endocrine therapy for bone metastasis from breast cancer].
    Sakurai T; Tatematsu H; Yamataka K; Yamamoto T; Kawahara H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2029-34. PubMed ID: 11791380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
    Feng J; Zheng X; Dai A
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):468-70. PubMed ID: 10920949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.
    Kopp HG; Krauss K; Fehm T; Staebler A; Zahm J; Vogel W; Kanz L; Mayer F
    Anticancer Res; 2011 Nov; 31(11):4025-30. PubMed ID: 22110237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
    Satoh Y; Une Y; Fujisawa J; Uchino J
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
    Tanaka Y; Ohmori Y; Toki T; Okazaki Y; Ogoshi S; Ogawa Y
    Nihon Geka Hokan; 1995 Jan; 64(1):15-22. PubMed ID: 8534185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
    Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of full-thickness chest wall resection as a local treatment for sternum metastasis of breast cancer].
    Hamazoe R; Takahashi S; Sumi K; Murata Y; Kinugasa Y; Shiota S; Hirooka Y
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1344-7. PubMed ID: 9703824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
    Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
    Rai Y; Emi Y; Nishijima N; Kai S; Kano T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy.
    Yang Q; Sakurai T; Yoshimura G; Suzuma T; Umemura T; Nakamura M; Nakamura Y; Mori I; Kakudo K
    Oncol Rep; 2003; 10(1):121-5. PubMed ID: 12469156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comprehensive treatment of bone metastases of breast cancer: a clinical analysis of 70 cases].
    Zhou J; Zhang Q; Lu H
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):284-6. PubMed ID: 11038760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic therapy, pain relief and quality of life of breast cancer patients with bone metastasis].
    Sonoo H; Shimozuma K; Kurebayashi J; Ohta K; Kiyono T
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():10-5. PubMed ID: 7747985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia].
    Terazaki Y; Nagamatsu H; Ono H; Iwakuma N; Shirouzu K
    Gan To Kagaku Ryoho; 2005 May; 32(5):675-7. PubMed ID: 15918571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
    Wang ZH; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer].
    Maeda T; Kubo Y; Sasajima T; Ikeda K; Hirata S; Yamazaki K; Nakajima S
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2165-9. PubMed ID: 8239681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.